Description
Anti-CD74 antibody-conjugated liposomes represent an innovative biotherapeutic strategy tailored for precise drug delivery in the treatment of various diseases, notably cancer and autoimmune conditions. By leveraging the high specificity of anti-CD74 antibodies, these liposomes can target and bind to cells that express the CD74 receptor, significantly improving therapeutic outcomes while reducing potential side effects associated with conventional treatments.
Reviews
There are no reviews yet.